A major factor in the decline of inflation is the simple fact that America’s workers were, in general, unable to raise their nominal wages in line with the rise in the cost of living

By Thomas Ferguson and Servaas Storm

Medicare negotiators need to have a deep understanding - both theoretical and empirical - of the learning processes involved in developing a drug to negotiate a price that is fair.

By Öner Tulum and William Lazonick

As the “Technoking” of Tesla strategizes to maintain his control over the company’s decision-making, anyone concerned with the role that Tesla will play in the evolving EV transition should be asking how CEO Musk might use, or abuse, his powerful position.

By Matt Hopkins and William Lazonick

By 1812 the U.S. already had more business corporations than any other country, and possibly more than all other countries put together, securing its role as the world’s first “corporation nation.”

By Richard Sylla and Robert E. Wright

Sensitivity of investment and valuation to drug price indices and market conditions

By Cody Hyman, Henry Dao, Gregory Vaughan, and Fred Ledley

The concentration of innovation in a handful of urban centers engenders large and persistent regional disparities in economic opportunity.

By Aakash Kalyani, Nicholas Bloom, Marcela Carvalho, Tarek Alexander Hassan, Josh Lerner, and Ahmed Tahoun